Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceSyndromeCombined Modality TherapyMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteTreatment OutcomeImmunosuppressive AgentsRemission InductionHematologic NeoplasmsGraft RejectionTime FactorsHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionImmunosuppressionLymphocyte DepletionStem Cell TransplantationAcute DiseaseLeukocyte TransfusionLymphoma, Non-HodgkinMyelodysplastic SyndromesHeart TransplantationSevere Combined ImmunodeficiencyT-LymphocytesChimeraColony-Forming Units AssaySurvival AnalysisHLA AntigensRetrospective StudiesLung TransplantationCyclosporineHematologic DiseasesActuarial AnalysisBone DensityLymphocyte TransfusionNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCarmustineOrgan TransplantationPancytopeniaFollow-Up StudiesGraft vs Tumor EffectCell DifferentiationLeukocyte CountGraft vs Leukemia EffectSurvival RateCytarabineCytomegalovirus InfectionsSpleenBone ResorptionGranulocyte Colony-Stimulating FactorMelphalanMice, Inbred BALB CDisease-Free SurvivalEtoposideFlow CytometryLymphomaMultiple MyelomaFatal OutcomeCells, CulturedPrognosisMice, KnockoutAntigens, CD34Hodgkin DiseaseInfectionCell TransplantationGranulocytes